Categories
Bal Pharma Limited — Board Meeting, 27-05-2026: Outcome of Board Meeting
27-05-2026 · 07:00 pm
Bal Pharma Board approved FY26 consolidated revenue of ₹311.66 Cr & profit of ₹6.32 Cr. Declared ₹1.20/share dividend (12%). Also approved 5 lakh employee stock options & 10 lakh preferential warrants to promoters. Mr. Shreepada ML appointed CS.
No comments yet. Be the first to comment!